To identify recurrent fusion gene transcripts (e.g., BCR::ABL1 and E2A::PBX1) in B-ALL, PCR is used to achieve sensitivity higher than 10−5 [47]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.